Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism in females is caused by high male hormones or sensitive hair follicles.

Facial feminization surgery is safe and patients are satisfied, but more detailed research is needed.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

Cyproterone acetate is effective for treating hirsutism, but some patients may feel worse on low-dose maintenance therapy.

Transgender patients on hormone therapy experience more acne and hair loss, but less skin inflammation.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Spironolactone and finasteride are equally effective for hirsutism in transgender women.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Testosterone treatment may affect heart response to stress in transgender men.

Flibanserin's effectiveness for low sexual desire in premenopausal women may vary based on hormone levels, with normal hormone levels showing better responses.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Finasteride helps reduce hidradenitis suppurativa symptoms in females.

Hormone testing may not be very helpful in diagnosing female pattern hair loss.

Check hormone levels in older women to find hidden conditions like certain tumors.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Cyproterone acetate and ethinylestradiol effectively reduce hirsutism and acne in women.

The woman's symptoms and tests suggest her adrenal glands are producing too many male hormones.

The treatment improved acne, seborrhoea, and hirsutism, with some side effects like spotting and nervousness.

Women with excessive body hair often have higher male hormones and related health issues.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Bilateral ovarian hyperthecosis is a rare but treatable cause of increased facial hair in postmenopausal women.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

A new method effectively predicts estrogen-related health effects for early screening.

Hormones significantly affect women's sexual function, and more research is needed to improve treatments for sexual dysfunction with minimal side effects.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

Topical finasteride didn't significantly reduce facial hair, but patients felt it helped.

Certain medications including flutamide, spironolactone, and others effectively reduce excessive hair growth in women, especially when combined with lifestyle changes.